Subscribe

  • How Can We Help You?

    Global Problem Solving from Covington: Deal with Complex Problems Anywhere in the World

Biotech Firms Mull Acquisition Offers Amid Shaky IPO Climate

Media Mention

Law360

Megan Gates’ commentary was included in a Law360 article covering how biotechnology firms are exploring acquisition offers from larger pharmaceutical companies as a more certain exit strategy in an uncertain initial public offering (IPO) environment. Megan observed that “companies I work with are definitely considering M&A opportunities, probably more so than they might otherwise have been, given the lackluster IPO path.”

Click here to read the full article

Share links:

Share links:

Related Professionals

Related Practices

Related Industries

Related Offices

Related Regions

Related News & Insights